0001576280-25-000169.txt : 20250609 0001576280-25-000169.hdr.sgml : 20250609 20250609214536 ACCESSION NUMBER: 0001576280-25-000169 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20250605 FILED AS OF DATE: 20250609 DATE AS OF CHANGE: 20250609 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Talasaz AmirAli CENTRAL INDEX KEY: 0001753159 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38683 FILM NUMBER: 251035824 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Guardant Health, Inc. CENTRAL INDEX KEY: 0001576280 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 454139254 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 BUSINESS PHONE: 855-698-8887 MAIL ADDRESS: STREET 1: 3100 HANOVER STREET CITY: PALO ALTO STATE: CA ZIP: 94304 4 1 wk-form4_1749519929.xml FORM 4 X0508 4 2025-06-05 0 0001576280 Guardant Health, Inc. GH 0001753159 Talasaz AmirAli 3100 HANOVER STREET PALO ALTO CA 94304 1 1 0 0 Co-Chief Executive Officer 1 Common Stock 2025-06-05 4 S 0 1680 50.0041 D 2187060 D Common Stock 2025-06-06 4 S 0 39751 50.0722 D 2147309 D Common Stock 2025-06-09 4 S 0 77853 50.0936 D 2069456 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2024. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.04 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.25 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.41 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John G. Saia, as attorney-in-fact for AmirAli Talasaz 2025-06-09